Implanon Nxt (Etonogestrel)

Etonogestrel, the active ingredient in Implanon Nxt, is a progestin presented as a 68 mg subdermal implant for subcutaneous use. It provides long‑acting hormonal contraception by preventing ovulation and altering cervical mucus in women of reproductive age.

GNH USA supplies Implanon Nxt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to WHO GMP standards and provides regulatory documentation for importers. Its global network ensures timely delivery and temperature‑controlled logistics where required. Clients benefit from dedicated technical support and post‑market surveillance services.

Etonogestrel is a progestin hormonal contraceptive that prevents pregnancy.

- Contraception: prevents pregnancy in women of reproductive age. - Family planning: offers a long‑acting reversible method of birth control lasting up to three years. - Hormonal birth control: provides continuous suppression of ovulation without daily dosing.

Implanon Nxt may cause